Cargando…
Anaplastic thyroid carcinoma with unusual long-term survival: a case report
BACKGROUND: Anaplastic thyroid carcinoma is a rare, rapidly progressive, and highly aggressive tumor. It has a global annual incidence of 1–2 per million people. It mostly affects older adults and women. The median survival duration after diagnosis does not exceed 6–8 months. CASE PRESENTATION: A 60...
Autores principales: | Moreno, Fany, Reyes, Clarisa, Pineda, César Alas, Castellanos, Gustavo, Cálix, Flory, Calderón, Jorge, Vasquez-Bonilla, Walter O. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8805419/ https://www.ncbi.nlm.nih.gov/pubmed/35101107 http://dx.doi.org/10.1186/s13256-021-03249-8 |
Ejemplares similares
-
Aggressive Multimodal Approach for Anaplastic Thyroid Cancer and Long-Term Survival
por: Hussain, Nasir, et al.
Publicado: (2013) -
Nomograms Predict Survival in Patients with Anaplastic Thyroid Carcinoma
por: Qiu, Bei, et al.
Publicado: (2019) -
Long-term survival of patients with anaplastic thyroid cancer after multimodal treatment
por: Lee, Haejun, et al.
Publicado: (2020) -
Survival Benefit of Intervention Treatment in Advanced Anaplastic Thyroid Cancer
por: Kasemsiri, Pornthep, et al.
Publicado: (2021) -
Response to neoadjuvant paclitaxel predicts survival in anaplastic thyroid carcinoma
por: Yamazaki, Haruhiko, et al.
Publicado: (2022)